efaproxiral has been researched along with Brain Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 11 (91.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curran, W; Gaspar, L; Gerber, M; Hackman, J; Kadish, S; Mehta, M; Murray, K; Pearlman, A; Scott, C; Shaw, E; Stea, B; Suh, J | 1 |
| Suh, JH | 1 |
| Abajian, MA; Demidenko, E; Dunn, JF; Grinberg, OY; Hou, H; Khan, N; Lu, S; O'Hara, JA; Steffen, RP; Swartz, HM; Wilmot, CM | 1 |
| Charpentier, MM | 1 |
| Sneed, PK | 1 |
| Boyd, AP; Cagnoni, PJ; Chang, EL; Fortin, A; Kresl, JJ; Mercier, JP; Nabid, A; Senzer, N; Shaw, E; Stea, B; Suh, JH | 1 |
| Boyd, AP; Cagnoni, PJ; Shaw, E; Stea, B; Suh, JH | 1 |
| Cannell, E | 1 |
| Engel, RH; Kaklamani, VG | 1 |
| Craig, M; Hackman, J; May, J; Pintér, T; Shaw, E; Stea, B; Steffen, RP; Suh, JH | 1 |
| Hackman, J; Nabid, A; Scott, C; Stea, B; Suh, J | 1 |
| Engelhard, H; Gerber, M; Grossman, SA; Kleinberg, L; Lesser, G; Pearlman, J; Piantadosi, S; Ruffer, J | 1 |
2 review(s) available for efaproxiral and Brain Neoplasms
| Article | Year |
|---|---|
Efaproxiral: a radiation enhancer used in brain metastases from breast cancer.
Topics: Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Propionates; Radiation-Sensitizing Agents | 2005 |
Role of efaproxiral in metastatic brain tumors.
Topics: Aniline Compounds; Animals; Brain Neoplasms; Breast Neoplasms; Humans; Propionates | 2006 |
7 trial(s) available for efaproxiral and Brain Neoplasms
| Article | Year |
|---|---|
RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.
Topics: Adult; Aged; Aniline Compounds; Brain Neoplasms; Dose Fractionation, Radiation; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Propionates; Radiation-Sensitizing Agents; Survival Analysis; Treatment Outcome | 2003 |
Efaproxiral: a novel radiation sensitiser.
Topics: Aniline Compounds; Animals; Brain Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Hemoglobins; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Injections, Intravenous; Multicenter Studies as Topic; Oxygen; Partial Pressure; Propionates; Radiation-Sensitizing Agents | 2004 |
Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
Topics: Adult; Aged; Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Propionates; Radiation Tolerance; Radiation-Sensitizing Agents | 2006 |
Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival.
Topics: Aged; Analysis of Variance; Aniline Compounds; Brain Neoplasms; Cranial Irradiation; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Oxygen; Propionates; Radiation-Sensitizing Agents; Treatment Outcome | 2006 |
Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases.
Topics: Aniline Compounds; Antisickling Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Drug; Erythrocytes; Female; Humans; Male; Middle Aged; Prognosis; Propionates; Survival Analysis | 2006 |
Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
Topics: Aged; Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Cranial Irradiation; Female; Humans; Middle Aged; Oxygen; Propionates; Quality of Life; Quality-Adjusted Life Years; Radiation Dosage; Radiation-Sensitizing Agents; Survival Rate | 2007 |
Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme.
Topics: Adult; Aged; Aniline Compounds; Antisickling Agents; Brain Neoplasms; Glioblastoma; Hemoglobins; Humans; Middle Aged; Propionates; Radiographic Image Enhancement; Survival Analysis | 1999 |
3 other study(ies) available for efaproxiral and Brain Neoplasms
| Article | Year |
|---|---|
Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.
Topics: Aniline Compounds; Animals; Brain Neoplasms; Cell Respiration; Hemoglobins; Male; Oxygen; Oxygen Consumption; Propionates; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344 | 2005 |
Efaproxiral: should we hold our breath?
Topics: Aniline Compounds; Brain Neoplasms; Cell Hypoxia; Cranial Irradiation; Humans; Propionates; Radiation Tolerance; Radiation-Sensitizing Agents | 2006 |
New hope for old drug in patients with brain metastases.
Topics: Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Propionates; Radiation-Sensitizing Agents | 2006 |